跳至主要内容
临床试验/NCT05440448
NCT05440448招募中不适用

Patch-free Occlusion Therapy

Retina Foundation of the Southwest2 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2024年4月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
68
试验地点
2
主要终点
Change in amblyopic eye visual acuity measured with a logMAR visual acuity chart

研究概览

简要总结

The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.

详细描述

This is a single-site randomized clinical trial to compare patch-free occlusion therapy with standard-of-care occlusion therapy with an adhesive patch in young children with amblyopia. Participants will be referred from local pediatric ophthalmologists. Following informed consent, children will complete baseline testing to confirm eligibility and provide pre-treatment measurements of visual acuity, suppression, stereoacuity, motor skills, self-perception, and quality of life. Eligible children will then be randomly allocated to either patch-free occlusion therapy or standard-of-care occlusion therapy with an adhesive patch.

Children will participate in their assigned occlusion therapy at home for 12 weeks (primary outcome). Adherence will be objectively monitored with a Theramon sensor. Vision will be re-assessed at 6 weeks and all tests will be repeated at 12 weeks. The patch-free occlusion group will have an option to continue the patch-free occlusion for and additional 6 or 12 weeks (24 weeks total). The standard-of-care occlusion group will be offered the opportunity to use the patch-free treatment at the 12 week visit through 24 weeks. Children who choose to remain in the study beyond the 12 week primary outcome visit will have vision reassessed at 18 and 24 weeks.

The primary analysis will be a comparison of improvement in amblyopic eye visual acuity (baseline-12 weeks) between the patch-free occlusion group and the standard-of-care patching group. Secondary analyses will include comparisons adherence to each treatment, comparison of the proportion of children in each group with visual acuity ≤0.1 logMAR (recovered) at 6 and 12 weeks visit and 95% CIs (at 6 and 12 weeks), comparisons of changes in extent of suppression, depth of suppression, stereoacuity, motor skills standard scores, self-perception scores, and PedEyeQ domain scores. Associations among hours of treatment, changes in visual acuity, suppression, and stereoacuity, will be explored and modeled for dose-response relationships. In exploratory analyses, we will examine whether there are additional improvements in visual acuity, suppression, or stereoacuity between 12 and 24 weeks for the patch-free group (12, 18, and 24 weeks means and 95% CIs).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 3-12 years
  • male and female
  • strabismic, anisometropic, or combined mechanism amblyopia (visual acuity: 0.3-0.8 logMAR)
  • interocular visual acuity difference ≥0.3 logMAR
  • wearing glasses (if needed) for a minimum of 8 weeks with no change in visual acuity at 2 visits ≥4 weeks apart
  • child's ophthalmologist and family willing to forgo standard patching treatment during the study

排除标准

  • Prematurity ≥8 wk
  • coexisting ocular or systemic disease
  • developmental delay
  • myopia > -3.00D

研究组 & 干预措施

Patch-free occlusion therapy

Experimental

干预措施: Patch-free occlusion therapy (Device)

Standard-of-care patching with an adhesive patch

Active Comparator

干预措施: Adhesive patch (Device)

结局指标

主要结局

Change in amblyopic eye visual acuity measured with a logMAR visual acuity chart

时间窗: 12 weeks

change in logMAR relative to baseline

次要结局

  • Change in motor skills assessed with the Movement Assessment Battery for Children-2(12 weeks)
  • Improvement in quality of life assesses with the Pediatric Eye Questionnaire(12 weeks)
  • Change in amblyopic eye visual acuity measured with a logMAR visual acuity chart(6,18, and 24 weeks)
  • Proportion of children who have recovered(6 and 12 weeks)
  • Change in extent of suppression assessed with W4 test(6 and 12 weeks)
  • Change in depth of suppression assessed with the contrast balance index(6 and 12 weeks)
  • Adherence to patching or viewing videos with glasses measured with a sensor(6 and 12 weeks)
  • change in stereoacuity assessed with the Randot Preschool Stereoacuity Test(6 and 12 weeks)
  • Change in self-perception assessed with the Pictorial Scale of Perceived Competence and Social Acceptance for Young Children(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eileen Birch

Senior Research Scientist

Retina Foundation of the Southwest

研究点 (2)

Loading locations...

相似试验